Search
-
News
Experts from MSK shared their work in more than 40 presentations and poster sessions at the 2023 meeting of ASTRO, the American Society for Therapeutic Radiology and Oncology.
… Wednesday, October 4, 2023 Researchers from Memorial Sloan Kettering Cancer Center (MSK) were recognized for their achievements at the 2023 meeting of ASTRO, the American Society for Therapeutic Radiology and Oncology. Teams reported new findings about radiation-induced secondary cancers, a new guidance
-
The Michael Kharas Lab
-
The Tuomas Tammela Lab
Research Technician, 2020-2022 Current Position: MD Student, Icahn School of Medicine at Mount Sinai
… Job Title M.D. Student, Icahn School of Medicine at Mount Sinai Research Technician, 2020-2022 Current Position: MD Student, Icahn School of Medicine at Mount Sinai Degree BS Start Year 2020 End Year 2022
-
Video
Touch therapist Rocco Caputo shows how to alleviate stomach pain.
… Touch therapist Rocco Caputo shows how to alleviate stomach pain. Rocco Caputo: Let’s talk about bellyaches. Usually bellyaches can come from gas, or if you haven’t pooped in a while. If it’s coming from gas, we can play rock paper, no scissors. You take your left hand and make a rock, you take your
-
-
… The Starr Foundation Program for Discovery Science recently launched the Grand Challenge Initiative (SD-GCI) to catalyze bold, collaborative basic research at Memorial Sloan Kettering. Designed to unite at least three independent laboratories around a single ambitious scientific question, the program
-
The Meng-Fu Bryan Tsou Lab
… Job Title Senior Research Scientist Email [email protected]
-
-
News
Find out when to consult a doctor for a bad headache.
… Monday, June 20, 2022 Summary MSK neuro-oncologist Lauren Schaff discusses when to see a doctor for a headache. Updated June 20, 2022 A bad headache can be a frightening experience. But sometimes, even scarier than the pounding in your head can be the tricks your mind plays on you as it’s happening.
-
Clinical Trial
… Full Title Phase Ib Trial of ABBV-637 or ABBV-155 in Combination with ERAS-801 for Glioblastoma with Amplification of the Epidermal Growth Factor Receptor Purpose This study is assessing ABBV-637 and ABBV-155 with ERAS-801 or standard treatment in people with glioblastoma. The people in this study have